CW
CALIFORNIA WATER SERVICE GROUP (CWT)·Q2 2025 Earnings Summary
Executive Summary
- Q2 2025 delivered a clear beat vs consensus: EPS $0.71 vs $0.56 and revenue $265.0M vs $243.5M, driven by tariff rate increases and 5% higher customer usage; GAAP EPS rose modestly year over year despite regulatory mechanism headwinds . Estimates from S&P Global.
- Management emphasized on-schedule progress in the 2024 California GRC with opening and reply briefs filed in July and a final law-and-motion hearing set for Aug. 5, a key catalyst toward a year-end decision .
- Capital deployment remained strong ($119.4M in Q2; $229.5M YTD), and Cal Water’s A+/Stable credit rating was affirmed, supporting liquidity for rate base growth and PFAS-related investments; first net PFAS settlement proceeds of $10.6M were received in May .
- Strategic expansion advanced with the Silverwood wastewater agreement (phase-one spend $60–$70M expected) and a 20-year solar PPA to lower energy costs (~$1.7M over term), reinforcing sustainability and cost management narratives .
- Near-term stock reaction drivers: revenue/EPS beat, visible regulatory timeline, and decoupling legislation momentum (SB 473 advancing through the California Assembly) that could improve earnings stability for water utilities .
What Went Well and What Went Wrong
What Went Well
- “Non‑GAAP EPS up 15% year over year” in 1H25, reflecting tariff rate changes and higher usage; Q2 revenue rose 8.5% to $265.0M, with usage up 5% year over year .
- Executed growth and sustainability initiatives: signed Silverwood wastewater agreement (15,000+ future connections), and a 20‑year solar PPA to reduce grid energy costs (~$1.7M over contract) .
- Credit strength and liquidity: A+/Stable rating affirmed for Cal Water; $240M available credit; capital investments $119.4M in Q2 and $229.5M YTD, supporting rate base growth trajectory .
What Went Wrong
- Operating expenses increased 8.7% (water production, other operations, and D&A), partly due to higher wholesale rates, usage, and lapping one‑time arrearage credits in Q2 2024; regulatory mechanism revenue decreased vs prior year .
- YTD GAAP revenue and EPS declined versus prior year due to 2024’s inclusion of 2023 interim rate relief; while non‑GAAP comparisons show improvement, GAAP optics remain noisy .
- Regulatory accounts and PFAS compliance timing create planning complexity; management noted potential timing shifts between treatment installation and well replacement to optimize long-term compliance costs .
Financial Results
Values with asterisk retrieved from S&P Global.
Versus estimates:
Estimates from S&P Global.
KPIs and balance sheet/liquidity:
Segment breakdown: Not applicable; Company reports consolidated regulated utility results .
Guidance Changes
Note: CWT does not provide formal EPS/Revenue guidance; regulatory proposals are forward-looking rate case items .
Earnings Call Themes & Trends
Management Commentary
- “Non‑GAAP earnings per share were up 15% year over year… considering it’s the third year of the rate case in California, which is our largest operating entity.” — CEO Marty Kropelnicki .
- “The primary drivers were tariff rate changes and increased customer usage, which combined added $0.52 per diluted share… offset mainly by revenue regulatory account decreases of $0.21 per share.” — CFO James Lynch .
- “Our Board… approved our 322nd quarterly dividend in the amount of $0.30 a share… a 10.71% increase (including the special dividend), with a five-year 7.7% dividend CAGR.” — CEO Marty Kropelnicki .
- “EPA proposed extending the compliance deadline… we remain committed to doing what we need to do to make sure that we exceed the water quality standards every day.” — CEO Marty Kropelnicki .
- “Senate Bill 473 would require the Public Utilities Commission to implement full decoupling for water utilities… passed the Senate 37–0, Assembly Utilities & Energy 15–0; awaiting Appropriations.” — CEO Marty Kropelnicki .
Q&A Highlights
- GRC timing: Management is “guardedly optimistic” given commissioner priority and procedural discipline; final hearing Aug. 5, then decision drafting by ALJ, supporting potential year-end resolution .
- PFAS capex timing: ~$160M treatment expected over next two years with remainder pushed to well replacements where optimal; customer health prioritized despite potential EPA timing shifts .
- Capex mix and Silverwood: Capex timing shifts are largely scheduling; the Board approved $60–$70M over two years for Silverwood phase-1; BVRT all‑party settlement reached, filing pending PUCT .
- Decoupling legislation: SB 473 advancing strongly; one opposition (Cal Advocates) citing ~$1M CPUC cost; management leading a broad coalition and views decoupling as critical to affordability and sustainability .
- PFAS settlements coverage: Management preliminarily estimates ~$40–$60M of the ~$226M PFAS program could be covered by settlements, subject to application allocations; more clarity expected by year-end .
Estimates Context
- Q2 2025: EPS $0.71 vs $0.56 consensus; revenue $265.0M vs $243.5M consensus — both beat. Drivers: tariff rate changes (+$23.9M) and 5% higher usage (+$7.0M), partially offset by prior-year regulatory mechanism revenue . Estimates from S&P Global.
- Q1 2025: EPS beat ($0.22 vs $0.16) but revenue miss ($204.0M vs $215.4M), reflecting lapping of 2023 interim rate relief recorded in Q1 2024 . Estimates from S&P Global.
- Expect estimate revisions to factor higher run-rate revenue from rate changes and usage, balanced against elevated water production costs and regulatory account dynamics . Estimates from S&P Global.
Key Takeaways for Investors
- Beat on both EPS and revenue in Q2 underscores underlying operational momentum despite regulatory mechanism noise; rate changes and usage are supportive into 2H25 .
- The 2024 CA GRC remains on schedule with key filings complete; a year-end decision is a material catalyst for earnings visibility and rate base growth .
- Liquidity and A+/Stable rating position CWT to fund robust capex ($119.4M in Q2; $229.5M YTD) and pursue PFAS compliance and strategic expansion (Silverwood, BVRT) with manageable balance sheet risk .
- Decoupling legislation (SB 473) could structurally stabilize earnings and improve affordability; legislative progress is a medium-term positive if enacted .
- PFAS program execution and settlement proceeds (~$10.6M received; potential ~$40–$60M coverage) reduce regulatory and capital cost uncertainty; watch timing shifts between treatment and well replacement .
- Sustainability initiatives (solar PPA) support cost management and emissions goals, adding incremental savings (~$1.7M) and reinforcing ESG credentials .
- Near-term trading: Positive skew from Q2 beat and regulatory timeline clarity; medium-term thesis centers on rate case outcomes, decoupling adoption, and disciplined capex driving rate base growth .
Notes: All document-based figures and statements are cited to company filings and press releases. Where consensus/estimate values are shown, they are from S&P Global. Values with asterisk in tables are retrieved from S&P Global.